We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+24.92%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$126M
AUM Growth
+$9.73M
Cap. Flow
+$224M
Cap. Flow %
177.31%
Top 10 Hldgs %
37.67%
Holding
493
New
153
Increased
113
Reduced
67
Closed
127

Top Buys

1
PG icon
Procter & Gamble
PG
+$3.82M
2
BMY icon
Bristol-Myers Squibb
BMY
+$2.47M
3
IBB icon
iShares Biotechnology ETF
IBB
+$2M
4
ULTA icon
Ulta Beauty
ULTA
+$1.86M
5
MON
Monsanto Co
MON
+$1.82M

Top Sells

1
MDVN
MEDIVATION, INC.
MDVN
+$7.18M
2
BIIB icon
Biogen
BIIB
+$4.33M
3
CALM icon
Cal-Maine
CALM
+$3.64M
4
AAPL icon
Apple
AAPL
+$2.74M
5
ALR
Alere Inc
ALR
+$2.22M

Sector Composition

1 Healthcare 39.95%
2 Consumer Staples 5.72%
3 Consumer Discretionary 5.14%
4 Technology 3.35%
5 Materials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATHM icon
376
Autohome
ATHM
$2.51B
– –
-19,015
Closed -$382K
ATHM icon
377
PUT
Autohome
ATHM
$2.51B
– –
-19,000
Closed -$154K
BBY icon
378
CALL
Best Buy
BBY
$18B
– –
-50,000
Closed -$67K
BIIB icon
379
Biogen
BIIB
$30.8B
– –
-14,632
Closed -$4.33M
BLUE
380
DELISTED
bluebird bio
BLUE
– –
-97
Closed -$70.3K
BMRN icon
381
BioMarin Pharmaceuticals
BMRN
$11.6B
– –
-21,373
Closed -$2.01M
BMRN icon
382
PUT
BioMarin Pharmaceuticals
BMRN
$11.6B
– –
-44,600
Closed -$90K
CALM icon
383
Cal-Maine
CALM
$4.18B
– –
-82,081
Closed -$3.64M
CALM icon
384
PUT
Cal-Maine
CALM
$4.18B
– –
-149,500
Closed -$610K
CCEP icon
385
Coca-Cola Europacific Partners
CCEP
$46.9B
– –
-12,104
Closed -$462K
CHTR icon
386
CALL
Charter Communications
CHTR
$16.4B
– –
-240
Closed -$21K
CLDX icon
387
Celldex Therapeutics
CLDX
$2.78B
– –
-87
Closed -$5.42K
CLDX icon
388
PUT
Celldex Therapeutics
CLDX
$2.78B
– –
-333
Closed -$2K
DD icon
389
DuPont de Nemours
DD
$18.1B
– –
-714
Closed -$95.2K
EPC icon
390
CALL
Edgewell Personal Care
EPC
$1.34B
– –
-10,000
Closed -$40K
ESPR
391
DELISTED
Esperion Therapeutics
ESPR
– –
-80,799
Closed -$916K
EXAS
392
CALL
DELISTED
Exact Sciences
EXAS
– –
-97,500
Closed -$62K
EXAS
393
PUT
DELISTED
Exact Sciences
EXAS
– –
-20,000
Closed -$6K
FXB icon
394
CALL
Invesco CurrencyShares British Pound Sterling Trust
FXB
$77.6M
– –
-42,700
Closed -$16K
FXB icon
395
PUT
Invesco CurrencyShares British Pound Sterling Trust
FXB
$77.6M
– –
-60,000
Closed -$562K
FXI icon
396
iShares China Large-Cap ETF
FXI
$4.6B
– –
-11,100
Closed -$380K
FXI icon
397
PUT
iShares China Large-Cap ETF
FXI
$4.6B
– –
-37,900
Closed -$23K
HLF icon
398
CALL
Herbalife
HLF
$1.28B
– –
-13,200
Closed -$24K
HLF icon
399
Herbalife
HLF
$1.28B
– –
-22,600
Closed -$661K
HLF icon
400
PUT
Herbalife
HLF
$1.28B
– –
-28,000
Closed -$68K
14 15
16
17 18

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q3 2016 Portfolio in Review

As of Q3 2016, FT Options held 493 positions worth $126M, up 8.4% from $116M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

FT Options deployed $224M of net new capital in Q3 2016, opening 153 new positions and adding to 113 existing holdings. Its largest new stake was iShares Biotechnology ETF: 21,000 shares worth $2.03M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 41% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $2.74M trimmed.

  • FT Options's largest Q3 2016 buy was iShares Biotechnology ETF: 21,000 shares worth $2.03M.
  • FT Options added most to Procter & Gamble in Q3 2016, an estimated $3.82M increase.
  • FT Options's biggest Q3 2016 reduction was Apple, cutting an estimated $2.74M.
  • FT Options fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $7.18M.
  • FT Options's ten largest holdings make up 38% of its $126M portfolio in Q3 2016.
  • FT Options opened 153 new positions and closed 127 in Q3 2016.
  • FT Options's portfolio value rose 8.4% quarter-over-quarter to $126M.

Based on FT Options's 13F filing for Q3 2016, filed 10 Nov 2016.